Success Stories: NIW Approval Received for an Indian Researcher III Working in the Field of Cancer Biology with Our Support

Client’s Testimonial:

“I would like to thank you and your office for accepting my case and helping me throughout the process.”

On August 16^th, 2021, we received another EB-2 NIW (National Interest Waiver) approval for a Researcher III in the Field of Cancer Biology (Approval Notice).

General Field: Cancer Biology

Position at the Time of Case Filing: Researcher III

Country of Origin: India

State of Residence at the Time of Filing: Minnesota

Approval Notice Date: August 16^th, 2021

Processing Time: 9 months, 24 days

Case Summary:

The application process for various immigration petitions at USCIS can be a tiring process without the aid of a legal firm. It is here that we come in with the accumulated expertise of thousands of case approvals. So, as soon as a client contacts us to hire our help in the adjudication process, we try our best to ascertain the potential of their claims before countersigning the retainer agreement.

In August 2021, we were approached by an Indian researcher III working in the field of cancer biology, to help him file an NIW (National Interest Waiver) application on his behalf. In order to ensure the success of his case, we went ahead and customized his petition to play to his strengths. This made us look at his professional and academic career thus far. In digging at these angles, we came up with information about his publications, citations as well as grants or funding he had received to date. We also made sure that the value of his ongoing work for the U.S. was not lost on the adjudicating judge. For this, we included a detailed overview of his CV and transcripts.

Some of the information we found helpful is as follows:

His proposed endeavor is to continue his research on identifying the changes in the gene expression profile and molecular pathways that cause cancer in order to develop prognostic biomarkers for predicting therapy effectiveness. His work is relevant to the development of more effective alternative therapies for the long-term treatment of cancer. His research addresses this imperative by facilitating the development of effective alternative treatments for cancer, thus his work holds significant financial and public health value for the United States.
His work has resulted in 9 peer-reviewed journal articles (1 of them first-authored), as well as 11 published poster abstracts.
His publications have also been cited a total of 42 times according to Google Scholar.
On the other hand, his research has been supported by funding from a leading agency, demonstrating the recognized value and importance of his work. This funding includes grants from the Department of Defense Ovarian Cancer Research Program.

Along with this information, we also suggested him to obtain letters of recommendation from experts in the field. One of these recommenders had the following to say about his work:

“As a whole, [his] vast wealth of experience in the field has afforded him with a comprehensive skill set and level of ingenuity that few researchers possess and has laid the foundation for his various scientific breakthroughs. In light of this outstanding background and his research achievements, [client] is a researcher of the highest rank, and his continued presence is of tremendous benefit to both the field of molecular biology and the United States.”

We are grateful to him for showing trust in our firm to represent him in his NIW case. We wish him the very best in life.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 47,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 47,000 in 2023.